Dr. Dave Khurana, MD

NPI: 1700945250
Total Payments
$10,879
2024 Payments
$782.95
Companies
21
Transactions
124
Medicare Patients
3,296
Medicare Billing
$972,412

Payment Breakdown by Category

Food & Beverage$4,079 (37.5%)
Consulting$3,500 (32.2%)
Other$1,770 (16.3%)
Travel$1,460 (13.4%)
Education$70.21 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,079 119 37.5%
Consulting Fee $3,500 1 32.2%
Honoraria $1,770 1 16.3%
Travel and Lodging $1,460 1 13.4%
Education $70.21 2 0.6%

Top Paying Companies

Company Total Records Latest Year
Outset Medical Inc $5,925 6 $0 (2023)
Horizon Therapeutics plc $2,092 14 $0 (2021)
AstraZeneca Pharmaceuticals LP $848.12 34 $0 (2024)
AKEBIA THERAPEUTICS INC $374.34 12 $0 (2024)
BARD PERIPHERAL VASCULAR, INC. $295.05 3 $0 (2019)
Relypsa, Inc. $276.55 16 $0 (2019)
Teleflex LLC $179.33 2 $0 (2024)
Mallinckrodt Enterprises LLC $119.96 6 $0 (2019)
Otsuka America Pharmaceutical, Inc. $118.36 4 $0 (2020)
Abbott Laboratories $115.05 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $782.95 28 AKEBIA THERAPEUTICS INC ($285.14)
2023 $5,733 13 Outset Medical Inc ($5,467)
2022 $730.11 14 Outset Medical Inc ($298.87)
2021 $327.46 13 AstraZeneca Pharmaceuticals LP ($192.09)
2020 $2,068 9 Horizon Therapeutics plc ($1,817)
2019 $639.49 28 Horizon Therapeutics plc ($228.17)
2018 $316.38 16 Relypsa, Inc. ($150.25)
2017 $281.61 3 Bard Peripheral Vascular, Inc. ($264.49)

All Payment Transactions

124 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/18/2024 AKEBIA THERAPEUTICS INC Vafseo (Drug) Education In-kind items and services $9.01 General
Category: Nephrology
12/11/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $16.18 General
Category: Nephrology
12/10/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $30.79 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
12/04/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $17.56 General
Category: Cardiovascular and Metabolism
11/20/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $14.87 General
Category: GASTROENTEROLOGY
11/06/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $25.57 General
Category: Cardiovascular and Metabolism
11/05/2024 AKEBIA THERAPEUTICS INC Vafseo (Drug) Food and Beverage In-kind items and services $15.92 General
Category: Nephrology
09/25/2024 AKEBIA THERAPEUTICS INC Food and Beverage In-kind items and services $146.20 General
09/18/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $31.73 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
09/05/2024 Teleflex LLC Titan SGS (Device) Food and Beverage In-kind items and services $75.35 General
Category: SURGICAL
09/04/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $22.22 General
Category: Immunology
09/03/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $23.99 General
Category: Cardiovascular and Metabolism
08/28/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $14.34 General
Category: Cardiovascular and Metabolism
08/20/2024 AKEBIA THERAPEUTICS INC Auryxia (Drug), Vafseo Food and Beverage In-kind items and services $7.76 General
Category: Nephrology
07/16/2024 AKEBIA THERAPEUTICS INC Vafseo (Drug) Food and Beverage In-kind items and services $75.35 General
Category: Nephrology
07/03/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $20.55 General
06/25/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.09 General
Category: Cardiovascular and Metabolism
06/04/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug), FARXIGA Food and Beverage In-kind items and services $29.55 General
Category: Cardiovascular and Metabolism
06/04/2024 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $8.07 General
Category: Nephrology
05/22/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $22.49 General
04/24/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.18 General
Category: Cardiovascular and Metabolism
04/03/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $22.76 General
03/20/2024 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $22.83 General
Category: Nephrology
03/06/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $30.61 General
Category: IMMUNOLOGY
02/28/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $19.57 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 684 1,624 $458,503 $194,651
2022 10 790 2,042 $536,776 $224,851
2021 12 840 2,111 $571,730 $250,068
2020 12 982 2,573 $762,987 $302,842
Total Patients
3,296
Total Services
8,350
Medicare Billing
$972,412
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 52 356 $166,252 $77,945 46.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 179 433 $89,198 $38,590 43.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 154 190 $75,240 $24,277 32.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 106 259 $52,577 $23,328 44.4%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2023 36 60 $21,540 $8,989 41.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 62 133 $18,753 $8,010 42.7%
90935 Hemodialysis procedure with physician evaluation Facility 2023 32 129 $18,447 $7,058 38.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 48 48 $15,264 $5,847 38.3%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 15 16 $1,232 $606.88 49.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 208 539 $111,034 $48,053 43.3%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 48 199 $92,933 $43,392 46.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 171 231 $91,476 $34,804 38.0%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2022 50 178 $63,902 $26,229 41.0%
90966 Home dialysis services per month (20 years or older) Office 2022 13 92 $42,872 $21,096 49.2%
90935 Hemodialysis procedure with physician evaluation Facility 2022 53 301 $43,043 $16,860 39.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 81 204 $41,412 $15,956 38.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 92 221 $31,161 $11,947 38.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 54 54 $17,172 $5,839 34.0%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 20 23 $1,771 $675.82 38.2%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 55 295 $137,765 $68,183 49.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 190 431 $88,786 $40,213 45.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 161 237 $93,852 $35,501 37.8%
90935 Hemodialysis procedure with one physician evaluation Facility 2021 53 410 $58,630 $22,943 39.1%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 42 71 $39,405 $18,771 47.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 70 197 $39,991 $15,747 39.4%

About Dr. Dave Khurana, MD

Dr. Dave Khurana, MD is a Nephrology healthcare provider based in Huntsville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700945250.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dave Khurana, MD has received a total of $10,879 in payments from pharmaceutical and medical device companies, with $782.95 received in 2024. These payments were reported across 124 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,079).

As a Medicare-enrolled provider, Khurana has provided services to 3,296 Medicare beneficiaries, totaling 8,350 services with total Medicare billing of $972,412. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Huntsville, TX
  • Active Since 12/08/2006
  • Last Updated 08/14/2025
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1700945250

Products in Payments

  • KRYSTEXXA (Biological) $2,074
  • LOKELMA (Drug) $566.31
  • Veltassa (Drug) $324.76
  • FARXIGA (Drug) $266.97
  • BPV-Lutonix (Device) $264.49
  • Auryxia (Drug) $201.36
  • ACTHAR (Biological) $186.21
  • PROCLAIM (Device) $115.05
  • DEKNATEL (Device) $103.98
  • Vafseo (Drug) $100.28
  • SAMSCA (Drug) $82.10
  • Titan SGS (Device) $75.35
  • PURIFIED CORTROPHIN GEL (Drug) $62.52
  • TARPEYO (Drug) $59.99
  • JYNARQUE (Drug) $36.26
  • Velphoro (Drug) $32.38
  • AVYCAZ (Drug) $30.71
  • Parsabiv (Biological) $27.51
  • Fabhalta (Drug) $22.22
  • FABRAZYME (Biological) $18.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Huntsville